Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKB-6548 effect on Celecoxib PK in healthy subjects
NCT02502500Phase 1Completed
- Sponsor
- Akebia Therapeutics
- Start
- Jul 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of vadadustat in anemia, sponsored by Akebia Therapeutics. Primary endpoint: Maximum Plasma Concentration at 48 hours. Started Jul 2015; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02502500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502500.